Sex Enhancement Chocolates Recalled Over Hidden Drug Ingredients
via HealthDay TUESDAY, March 31, 2026 — Two chocolate products marketed for sexual enhancement are being recalled because they were found to contain hidden prescription drug ingredients.
The recall involves "Gold Lion Aphrodisiac Chocolate" and "ilum Sex Chocolate," sold by the company Gear Isle, according to the U.S. Food and Drug Administration (FDA).
Officials said the products contain sildenafil and tadalafil, but these ingredients were not listed on the label.
Hidden drug ingredients can be dangerous, especially for folks taking certain medications.
Anyone who takes nitrates for a heart condition, such as nitroglycerin, is at particular risk, the FDA’s announcement said. Combining nitrates with sildenafil or tadalafil can cause a sudden and potentially life-threatening drop in blood pressure.
Health officials warn that this risk is especially important for adult men, who are more likely to use both these products and heart medications.
So far, no illnesses have been reported.
The recalled items include:
Gold Lion Aphrodisiac Chocolate
ilum Sex Chocolate
Both products were sold online across the United States and labeled as dietary supplements.
Gear Isle says customers should stop using the products right away and return them for a refund.
Anyone who has used the products and feels sick should contact a doctor immediately.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-01 01:57
Read more
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Why You And Your Pooch Share Similar Reactions to Life
- ACC: Higher Ultraprocessed Food Consumption Tied to Increased Risk for Atherosclerotic CVD
- Single-Tablet Bictegravir-Lenacapavir Noninferior to Complex Regimens for HIV-1
- GLP-1 Receptor Agonists Similarly Effective Across Age, Race, Starting Weight
- Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions